statistiche ricercatore

Continente	#
NA - Nord America	386
AS - Asia	290
EU - Europa	275
SA - Sud America	52
Continente sconosciuto - Info sul continente non disponibili	22
AF - Africa	8
OC - Oceania	2
Totale	1.035

Nome	#
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia	123
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients	115
Richter's transformation in the heart	108
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS	105
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION	104
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes	99
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION	94
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients	81
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS	77
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia	72
Collision diffuse large B cell lymphoma and myeloid sarcoma in the liver	57
Totale	1.035

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	13	0	0	0	1	1	0	0	2	1	1	3	4
2022/2023	69	5	13	2	5	5	8	0	0	21	1	5	4
2023/2024	111	1	5	2	0	0	0	10	0	2	3	55	33
2024/2025	272	20	19	27	5	35	20	15	25	30	12	40	24
2025/2026	497	45	34	24	85	90	42	59	26	39	43	9	1
2026/2027	58	5	7	22	24	0	0	0	0	0	0	0	0
Totale													1.035

IRIS - Res&Arch Institutional Research Information System - Research & Archive